COMMUNIQUÉS West-GlobeNewswire
      -   
  
Intercept Pharmaceuticals Announces Pricing of Upsized $250 Million Public Offering and Concurrent Private Placement of Common Stock
05/04/2018 -   
  
Rockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical Meetings
05/04/2018 -   
  
MediPharm Labs Receives Cannabis Oil Production License
05/04/2018 -   
  
Imaging3 Engages Renowned MZ Group to Expand Investor Awareness and Shareholder Communication Program
05/04/2018 -   
  
Zecotek Provides Update for Zecotek Imaging China
05/04/2018 -   
  
Progressive Care: S. Mars, CEO Releases Open Letter to Shareholders
05/04/2018 -   
  
ICC Labs Announces New Initiative to Conduct Various Scientific and Medicinal Research Activities
05/04/2018 -   
  
Aeglea BioTherapeutics to Present Pegzilarginase Phase 1 Dose Escalation Data in Patients with Advanced Solid Tumors at 2018 AACR Annual Meeting
05/04/2018 -   
  
BioSig Technologies Issues 2018 Shareholder Letter
05/04/2018 -   
  
PhaseBio Announces Completion of Dosing in First Cohort of Phase 1 Clinical Trial of PB2452, a Reversal Agent for Ticagrelor
05/04/2018 -   
  
HempAmericana Files Permits for Licensed Grower Status as High-Capacity CBD Oil Operation Nears Full-Scale Production
05/04/2018 -   
  
Cue Biopharma to Present at Bloomberg Biotech Innovations Conference
05/04/2018 -   
  
Theratechnologies Announces Financial Results for First Quarter of 2018
05/04/2018 -   
  
Theratechnologies annonce ses résultats financiers du premier trimestre de 2018
05/04/2018 -   
  
VitalHub Announces Listing on Frankfurt Stock Exchange
05/04/2018 -   
  
BioCorRx Partner, Virtual Reality Medical Center, Submits Small Business Innovation Grant Application to the National Institute of Health
05/04/2018 -   
  
Evolus Phase III European - Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to Botox® Meets Primary Endpoint
05/04/2018 -   
  
DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer
05/04/2018 -   
  
Sonoma Pharmaceuticals Announces FDA Approval for Antimicrobial Post-Therapy Gel
05/04/2018 
Pages